Myc-Driven, Primary Mouse Lymphoma Expressing Human CD22 Are Highly Infiltrated By Syngeneic Immune Cells and Provide a Unique Model to Test CD22-Targeted Therapies
Wagner F, Brandl C, Emmerich C, Mackensen A, Nitschke L, Müller F (2018)
Publication Type: Conference contribution
Publication year: 2018
Journal
Publisher: AMER SOC HEMATOLOGY
City/Town: WASHINGTON
Conference Proceedings Title: BLOOD
Event location: San Diego, CA
DOI: 10.1182/blood-2018-99-110284
Authors with CRIS profile
Franziska Gsottberger
Department of Medicine 5 – Haematology and Oncology
Carolin Brandl
Sonderforschungsbereich/Transregio 130 B-Zellen: Immunität und Autoimmunität
Andreas Mackensen
Lehrstuhl für Innere Medizin V
Lars Nitschke
Professur für Genetik
Fabian Müller
Department of Medicine 5 – Haematology and Oncology
How to cite
APA:
Wagner, F., Brandl, C., Emmerich, C., Mackensen, A., Nitschke, L., & Müller, F. (2018). Myc-Driven, Primary Mouse Lymphoma Expressing Human CD22 Are Highly Infiltrated By Syngeneic Immune Cells and Provide a Unique Model to Test CD22-Targeted Therapies. In BLOOD. San Diego, CA, US: WASHINGTON: AMER SOC HEMATOLOGY.
MLA:
Wagner, Franziska, et al. "Myc-Driven, Primary Mouse Lymphoma Expressing Human CD22 Are Highly Infiltrated By Syngeneic Immune Cells and Provide a Unique Model to Test CD22-Targeted Therapies." Proceedings of the 60th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA WASHINGTON: AMER SOC HEMATOLOGY, 2018.
BibTeX: Download